These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma. Leng J; Zhang L; Yao H; Cao X Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin]. Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284 [TBL] [Abstract][Full Text] [Related]
28. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models. Qin XQ; Beckham C; Brown JL; Lukashev M; Barsoum J Mol Ther; 2001 Oct; 4(4):356-64. PubMed ID: 11592839 [TBL] [Abstract][Full Text] [Related]
29. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma. Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345 [TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871 [TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta. Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975 [TBL] [Abstract][Full Text] [Related]
32. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Pietersen AM; van der Eb MM; Rademaker HJ; van den Wollenberg DJ; Rabelink MJ; Kuppen PJ; van Dierendonck JH; van Ormondt H; Masman D; van de Velde CJ; van der Eb AJ; Hoeben RC; Noteborn MH Gene Ther; 1999 May; 6(5):882-92. PubMed ID: 10505114 [TBL] [Abstract][Full Text] [Related]
34. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Wang L; Tang ZY; Qin LX; Wu XF; Sun HC; Xue Q; Ye SL Hepatology; 2000 Jul; 32(1):43-8. PubMed ID: 10869287 [TBL] [Abstract][Full Text] [Related]
35. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994 [TBL] [Abstract][Full Text] [Related]
36. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice. Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells. Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209 [TBL] [Abstract][Full Text] [Related]
38. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
39. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir. Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863 [TBL] [Abstract][Full Text] [Related]
40. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]